Table 1.

Patient demographics and baseline characteristics

Characteristic	Values n (%) or median (95%CI)
Total	120 (100.0)
Male	86(71.7)
Female	34 (28.3)
Age	63.2(60.9–65.4)
Race
Caucasian	99 (82.5)
African American	11 (9.2)
Hispanic	4 (3.3)
Asian	5 (4.2)
Unknown	1 (0.8)
BSA (m2)	2.0(1.9–2.0)
Study/Disease
BAY-BEV / Solid tumors	27 (22.5)
BAY-KS / Kaposi’s sarcoma	8 (6.7)
BAY-CRPC / Prostate	46 (38.3)
BAY-NSCLC / Lung	22(18.3)
BAY-CRC / Colorectal	17(14.2)
Albumin (g/dL)	3.6(3.5–3.7)
Alkaline Phosphatase (U/L)	81.0(74.0–89.0)
Total Bilirubin (mg/dL)	0.6 (0.6–0.7)
SGOT (U/L)	26 (24–28)
CrCl (mL/min)	90.9 (84.8–97.7)
CrCl <60mL/min	17(14.2)